FDA Approves Lamisil For Pediatric Treatment Of Scalp Ringworm - Medication Comes In Easy To Take Granules
Oct 2nd, 2007 | By | Category: Health NewsThe U.S. Food and Drug Administration announced the approval of Lamisil Oral Granules for the treatment of tinea capitis, a fungal infection of the scalp, in children ages 4 years and older. Tinea capitis most commonly affects children and is often characterized by severe itching, dandruff and bald patches. It is a persistent and contagious fungal infection that usually does not respond to topical treatment. [click link for full article]
